Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Personality characteristics in MS patients: The role of avoidant personality.
Simvastatin inhibits secretion of Th17-polarizing cytokines and antigen presentation by DCs in patients with relapsing remitting multiple sclerosis.
A new computerised cognitive test for the detection of information processing speed impairment in multiple sclerosis.
High and dysregulated secretion of epidermal growth factor from immune cells of patients with relapsing-remitting multiple sclerosis.
[New treatment options in multiple sclerosis and their complications].
Effect of IL-17A blockade with secukinumab in autoimmune diseases.
OASIS is Automated Statistical Inference for Segmentation, with applications to multiple sclerosis lesion segmentation in MRI.
Evaluation of changes in retinal nerve fiber layer thickness and visual functions in cases of optic neuritis and multiple sclerosis.
Health-related quality of life in partners of persons with MS: a longitudinal 10-year perspective.
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.
Melanoma complicating treatment with natalizumab for multiple sclerosis.
No association of IFI16 (interferon-inducible protein 16) variants with susceptibility to multiple sclerosis.
Miscellaneous indications for extracorporeal photochemotherapy (ECP).
Substance Name: ONO 4641
Prevalence of multiple sclerosis symptoms across lifespan: data from the NARCOMS Registry.
Hepatocyte growth factor mediates mesenchymal stem cell-induced recovery in multiple sclerosis models.
Network meta-analysis models to account for variability in treatment definitions: application to dose effects.
The Alzheimer's disease-associated amyloid beta-protein is an antimicrobial peptide.
The dynamics of finger tremor in multiple sclerosis is affected by whole body position.
Gait variability and disability in multiple sclerosis.
Analyses of haptoglobin level in the cerebrospinal fluid and serum of patients with neuromyelitis optica and multiple sclerosis.
The combination of cyclophosphamide plus interferon beta as rescue therapy could be used to treat relapsing-remitting multiple sclerosis patients-- twenty-four months follow-up.
Self-tolerance in multiple sclerosis.
Pathogenic features of CD4(+)CD28(-) T cells in immune disorders.
Low dose zymosan ameliorates both chronic and relapsing experimental autoimmune encephalomyelitis.

Pages